WHCB: “Swiss Re’s Study of China’s Health Care System Worth a Look”

“Wall Street Journal’s Nicholas Zamiska wrote today (subscription required) that China’s government is struggling with its health care reform because the system is ‘marred by rampant over-prescription and other shortcomings’ and that ‘is slowing the development of private medical insurance in China . . . limiting Beijing’s options as it strives to rebuild the system.’”

See my complete post over at World Health Care Blog.


Leave a Reply